James A. Geraghty
Board of Directors
Greenberg Traurig
Liechtenstein
Biography
Jim Geraghty has been a director of the Company since May 2015 and was elected Chairman of the Board in July 2015. He is an industry leader with 30 years of strategic and leadership experience, including more than 20 years as a senior member of executive teams at biotechnology companies developing and commercializing innovative therapies. Mr. Geraghty serves as Chairman of the Board of Idera Pharmaceuticals. He also serves a director on the Boards of Pieris Pharmaceuticlas, Inc., Fulcrum Therapeutics, Inc., Voyager Therapeutics, Inc., and BIO Ventures for Global Health
Research Interest
Business Developmen
